Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Randomized Phase III Trial of Neoadjuvant Immunotherapy with Response-Adapted Treatment versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma

Head/Neck

Disease Sites: Head/Neck

Phase: III

Investigator: Choe, Jennifer

NCTID: NCT06568172

Protocol No: NRGHNHN014

A First-In-Human, Phase 1, Dose-Escalation Study of SGR-3515 In Participants with Advanced Solid Tumors

Disease Sites: Not Available

Phase: I

Investigator: Gibson, Mike

NCTID: NCT06463340

Protocol No: VICC-DTPHI24100

A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus PostTransplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

Multiple Cancer Types

Disease Sites: Leukemia, Lymphoma

Phase: III

Investigator: Dholaria, Bhagirathbhai

NCTID: NCT06615050

Protocol No: VICC-DTCTT23454

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form